Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Ottawa

$19,936.00

The electrophysiology and neuropharmacology of nicotine modulated attention

FY 2010-11

Summary
On a daily basis, we are faced with cluttered environments with sensory inputs that compete for our mental resources and, ultimately, for the control of behaviour. Coherent goal-directed behaviour relies on selection mechanisms in the brain to control the flow of these inputs by allocating attention to goal-relevant stimuli rather than to goal-irrelevant distractors. Acetylcholine is a neurotransmitter in the brain which is known to regulate ""selective attention"", but exactly how it accomplishes this is unclear. Some animal and human research suggests that acetylcholine may facilitate attention by amplifying relevant inputs in the sensory areas of the brain, thus making them easier to detect and discriminate from other (irrelevant) input. In contrast to this ""attentional facilitation"" hypothesis, other research suggests that acetylcholine may improve selective attention by actively suppressing the sensory impact of irrelevant stimuli. The objective of our research is to examine these two hypotheses by administering drugs which temporarily alter brain acetylcholine and examining how this alteration affects the processing of target and distractor information in auditory and visual tasks. In these studies, performance speed and accuracy will be assessed along with brain electrical activity which can help determine whether acetylcholine affects early (at the sensory level) or late (decision making level) processing stages. Acetylcholine will be manipulated by administering single doses of nicotine, a drug that increases levels of acetylcholine in the brain. As acetylcholine activates a number of different types of acetylcholine receptor systems, other studies will administer drugs which selectively block one or more of these receptors. Drugs will be administered in a double-blind design with placebo controls. This research will help to enlighten our knowledge of acetylcholine's role in human attention.
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
355737-2008
Name nom
Knott, Verner
Department département
Psychology, School of
Organization id
28
Institution établissement
University of Ottawa
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2008
Award amount
19936
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
12
Committee name en
Psychology: Brain, Behaviour & Cognitive Sciences
Committee name fr
Psychologie: Cerveau, comportement et science cognitive
Area of application code
1210
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Psychology
Area of application fr
Psychologie
Research subject code
6307
Research subject group en
Psychology
Research subject group fr
Psychologie
Research subject en
Cognitive science -- other
Research subject fr
Science cognitive -- autres
Partie
3
Nb partie
5
Application title
The electrophysiology and neuropharmacology of nicotine modulated attention
Keyword
NSERC
Application summary
On a daily basis, we are faced with cluttered environments with sensory inputs that compete for our mental resources and, ultimately, for the control of behaviour. Coherent goal-directed behaviour relies on selection mechanisms in the brain to control the flow of these inputs by allocating attention to goal-relevant stimuli rather than to goal-irrelevant distractors. Acetylcholine is a neurotransmitter in the brain which is known to regulate ""selective attention"", but exactly how it accomplishes this is unclear. Some animal and human research suggests that acetylcholine may facilitate attention by amplifying relevant inputs in the sensory areas of the brain, thus making them easier to detect and discriminate from other (irrelevant) input. In contrast to this ""attentional facilitation"" hypothesis, other research suggests that acetylcholine may improve selective attention by actively suppressing the sensory impact of irrelevant stimuli. The objective of our research is to examine these two hypotheses by administering drugs which temporarily alter brain acetylcholine and examining how this alteration affects the processing of target and distractor information in auditory and visual tasks. In these studies, performance speed and accuracy will be assessed along with brain electrical activity which can help determine whether acetylcholine affects early (at the sensory level) or late (decision making level) processing stages. Acetylcholine will be manipulated by administering single doses of nicotine, a drug that increases levels of acetylcholine in the brain. As acetylcholine activates a number of different types of acetylcholine receptor systems, other studies will administer drugs which selectively block one or more of these receptors. Drugs will be administered in a double-blind design with placebo controls. This research will help to enlighten our knowledge of acetylcholine's role in human attention.